pyrilamine has been researched along with Atrophy in 1 studies
Pyrilamine: A histamine H1 antagonist. It has mild hypnotic properties and some local anesthetic action and is used for allergies (including skin eruptions) both parenterally and locally. It is a common ingredient of cold remedies.
mepyramine : An ethylenediamine derivative that is ethylenediamine in which one of the amino nitrogens is substituted by two methyl groups and the remaining amino nitrogen is substituted by a 4-methoxybenzyl and a pyridin-2-yl group.
Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lozeva, V | 1 |
| Valjakka, A | 1 |
| Lecklin, A | 1 |
| Olkkonen, H | 1 |
| Hippeläinen, M | 1 |
| Itkonen, M | 1 |
| Plumed, C | 1 |
| Tuomisto, L | 1 |
1 other study available for pyrilamine and Atrophy
| Article | Year |
|---|---|
Effects of the histamine H(1) receptor blocker, pyrilamine, on spontaneous locomotor activity of rats with long-term portacaval anastomosis.
Topics: Animals; Atrophy; Autoradiography; Circadian Rhythm; Eating; Histamine H1 Antagonists; Ligands; Live | 2000 |